Journal of Neurology

, Volume 259, Issue 3, pp 482–490 | Cite as

The relationship between clinical and pathological variables in Richardson’s syndrome

  • Emma C. Schofield
  • John R. Hodges
  • Thomas H. Bak
  • John H. Xuereb
  • Glenda M. Halliday
Original Communication

Abstract

In order to determine the relationship between regional neuropathology and severity of clinical features in Richardson’s syndrome (PSP-RS), the following hypotheses were tested: (1) executive dysfunction relates to prefrontal pathology; (2) language difficulties to pathology in Broca’s area and/or the perirhinal cortex; and (3) visuospatial impairment to pathology in the supramarginal region. A prospectively studied case series of brain donors at a specialist clinic in Addenbrooke’s Hospital Cambridge, UK, were examined. All those fulfilling postmortem criteria for PSP-RS and their last cognitive assessment within 24 months of death (N = 11/25) were included. The degree of regional neuronal loss and neuronal tau deposition across a number of cortical brain regions was performed and compared to 10 age- and sex-matched controls from the Sydney Brain Bank. Stepwise multiple linear regressions were used to determine the neuropathological correlates to cognitive scores and revealed the following. Executive dysfunction, as indexed by letter fluency, related to the degree of tau deposition in the superior frontal gyrus and supramarginal cortices (p < 0.020), language deficits related to neuron loss in the perirhinal gyrus (p < 0.001) and tau deposition in Broca’s area (p = 0.020), while visuospatial dysfunction and global cognitive impairment related to tau deposition in the supramarginal gyrus (p < 0.007). The severity of cognitive deficits relate to regional cortical tau deposition in PSP-RS, although language impairment related to neuronal loss in the perirhinal region. Global cognitive dysfunction related most to the severity of tau deposition in the supramarginal gyrus warranting further research on the role of this brain region in PSP-RS.

Keywords

Richardson’s syndrome Progressive supranuclear palsy Neuropathology Cognition Tau Correlations 

References

  1. 1.
    Agosta F, Kostic VS, Galantucci S, Mesaros S, Svetel M, Pagani E, Stefanova E, Filippi M (2010) The in vivo distribution of brain tissue loss in Richardson’s syndrome and PSP-parkinsonism: a VBM-DARTEL study. Eur J Neurosci 32:640–647PubMedCrossRefGoogle Scholar
  2. 2.
    Alexander MP, Stuss DT, Picton T, Shallice T, Gillingham S (2007) Regional frontal injuries cause distinct impairments in cognitive control. Neurology 68:1515–1523PubMedCrossRefGoogle Scholar
  3. 3.
    Bak TH, Caine D, Hearn VC, Hodges JR (2006) Visuospatial functions in atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry 77:454–456PubMedCrossRefGoogle Scholar
  4. 4.
    Bak TH, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR (2005) Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase 11:268–273PubMedCrossRefGoogle Scholar
  5. 5.
    Bak TH, Hodges JR (2003) Kissing and dancing—a test to distinguish the lexical and conceptual contributions to noun/verb and action/object dissociation. Preliminary results in patients with frontotemporal dementia. J Neurolinguist 16:169–181CrossRefGoogle Scholar
  6. 6.
    Bak TH, O’Donovan DG, Xuereb JH, Boniface S, Hodges JR (2001) Selective impairment of verb processing associated with pathological changes in Brodmann areas 44 and 45 in the motor neurone disease-dementia-aphasia syndrome. Brain 124:103–120PubMedCrossRefGoogle Scholar
  7. 7.
    Bergeron C, Pollanen MS, Weyer L, Lang AE (1997) Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration. J Neuropathol Exp Neurol 56:726–734PubMedGoogle Scholar
  8. 8.
    Bigio EH, Brown DF, CLr White (1999) Progressive supranuclear palsy with dementia: cortical pathology. J Neuropathol Exp Neurol 58:359–364PubMedCrossRefGoogle Scholar
  9. 9.
    Bird CM, Papadopoulou K, Ricciardelli P, Rossor MN, Cipolotti L (2004) Monitoring cognitive changes: psychometric properties of six cognitive tests. Br J Clin Psychol 43:197–210PubMedCrossRefGoogle Scholar
  10. 10.
    Bishop DVM (1983) The Test for Reception of Grammar. In: The Author. Age and Cognitive Performance Research Centre, University of Manchester, UKGoogle Scholar
  11. 11.
    Brown RG, Lacomblez L, Landwehrmeyer BG, Bak T, Uttner I, Dubois B, Agid Y, Ludolph A, Bensimon G, Payan C, Leigh NP (2010) Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain 133:2382–2393PubMedCrossRefGoogle Scholar
  12. 12.
    Corbetta M, Shulman GL (2002) Control of goal-directed and stimulus-driven attention in the brain. Nat Rev Neurosci 3:201–215PubMedCrossRefGoogle Scholar
  13. 13.
    Cordato NJ, Duggins AJ, Halliday GM, Morris JG, Pantelis C (2005) Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain 128:1259–1266PubMedCrossRefGoogle Scholar
  14. 14.
    Cordato NJ, Pantelis C, Halliday GM, Velakoulis D, Wood SJ, Stuart GW, Currie J, Soo M, Olivieri G, Broe GA, Morris JG (2002) Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. Brain 125:789–800PubMedCrossRefGoogle Scholar
  15. 15.
    Croot K, Hodges JR, Patterson K (1999) Evidence for impaired sentence comprehension in early Alzheimer’s disease. J Int Neuropsychol Soc 5:393–404PubMedCrossRefGoogle Scholar
  16. 16.
    Davies RR, Halliday GM, Xuereb JH, Kril JJ, Hodges JR (2009) The neural basis of semantic memory: evidence from semantic dementia. Neurobiol Aging 30:2043–2052PubMedCrossRefGoogle Scholar
  17. 17.
    Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA (2010) Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol 23:394–400PubMedCrossRefGoogle Scholar
  18. 18.
    Dudas RB, Berrios GE, Hodges JR (2005) The Addenbrooke’s cognitive examination (ACE) in the differential diagnosis of early dementias versus affective disorder. Am J Geriatr Psychiatry 13:218–226PubMedGoogle Scholar
  19. 19.
    Esmonde T, Giles E, Gibson M, Hodges JR (1996) Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy. J Neurol 243:638–643PubMedCrossRefGoogle Scholar
  20. 20.
    Ghosh BC, Rowe JB, Calder AJ, Hodges JR, Bak TH (2009) Emotion recognition in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 80:1143–1145PubMedCrossRefGoogle Scholar
  21. 21.
    Golbe LI (1997) Medical Advisory Board of the Society for Progressive Supranuclear Palsy. A clinical rating scale and staging system for progressive supranuclear palsy. Neurology 48:A326Google Scholar
  22. 22.
    Golbe LI, Ohman-Strickland PA (2007) A clinical rating scale for progressive supranuclear palsy. Brain 130:1552–1565PubMedCrossRefGoogle Scholar
  23. 23.
    Halliday GM, Hardman CD, Cordato NJ, Hely MA, Morris JG (2000) A role for the substantia nigra pars reticulata in the gaze palsy of progressive supranuclear palsy. Brain 123(Pt 4):724–732PubMedCrossRefGoogle Scholar
  24. 24.
    Hanihara T, Amano N, Takahashi T, Nagatomo H, Yagashita S (1995) Distribution of tangles and threads in the cerebral cortex in progressive supranuclear palsy. Neuropathol Appl Neurobiol 21:319–326PubMedCrossRefGoogle Scholar
  25. 25.
    Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I (1994) Preliminary NINDS neuropathologic criteria for Steele–Richardson–Olszewski syndrome (progressive supranuclear palsy). Neurology 44:2015–2019PubMedGoogle Scholar
  26. 26.
    Hayden BY, Platt ML (2010) Neurons in anterior cingulate cortex multiplex information about reward and action. J Neurosci 30:3339–3346PubMedCrossRefGoogle Scholar
  27. 27.
    Hodges JR (2007) Cognitive assessment for clinicians. Oxford University Press, OxfordGoogle Scholar
  28. 28.
    Hof PR, Delacourte A, Bouras C (1992) Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases. Acta Neuropathol (Berl) 84:45–51CrossRefGoogle Scholar
  29. 29.
    Howard D, Patterson K (1992) Pyramids and palm trees: a test of semantic access from pictures and words. Thames Valley Test Company, Bury St EdmundsGoogle Scholar
  30. 30.
    Jellinger KA (2008) Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Neurodegener Dis 5:339–346PubMedCrossRefGoogle Scholar
  31. 31.
    Josephs KA, Boeve BF, Duffy JR, Smith GE, Knopman DS, Parisi JE, Petersen RC, Dickson DW (2005) Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase 11:283–296PubMedCrossRefGoogle Scholar
  32. 32.
    Josephs KA, Whitwell JL, Dickson DW, Boeve BF, Knopman DS, Petersen RC, Parisi JE, Jack CR Jr (2008) Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging 29:280–289PubMedCrossRefGoogle Scholar
  33. 33.
    Kersaitis C, Halliday GM, Kril JJ (2004) Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies. Acta Neuropathol 108:515–523PubMedCrossRefGoogle Scholar
  34. 34.
    Kril JJ, Halliday GM, Svoboda MD, Cartwright H (1997) The cerebral cortex is damaged in chronic alcoholics. Neuroscience 79:983–998PubMedCrossRefGoogle Scholar
  35. 35.
    Litvan I (1994) Cognitive disturbances in progressive supranuclear palsy. J Neural Transm Suppl 42:69–78PubMedGoogle Scholar
  36. 36.
    Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, Quinn N, Sethi KD, Shults C, Wenning GK (2003) Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18:467–486PubMedCrossRefGoogle Scholar
  37. 37.
    Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, McKee A, Dickson D, Bancher C, Tabaton M, Jellinger K, Anderson DW (1996) Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 55:97–105PubMedCrossRefGoogle Scholar
  38. 38.
    Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR (2000) A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia. Neurology 55:1613–1620PubMedGoogle Scholar
  39. 39.
    Millar D, Griffiths P, Zermansky AJ, Burn DJ (2006) Characterizing behavioral and cognitive dysexecutive changes in progressive supranuclear palsy. Mov Disord 21:199–207PubMedCrossRefGoogle Scholar
  40. 40.
    Rushworth MF, Paus T, Sipila PK (2001) Attention systems and the organization of the human parietal cortex. J Neurosci 21:5262–5271PubMedGoogle Scholar
  41. 41.
    Schofield EC, Hodges JR, Macdonald V, Cordato NJ, Kril JJ, Halliday GM (2010) Cortical atrophy differentiates Richardson’s syndrome from the parkinsonian form of progressive supranuclear palsy. Mov Disord. doi:10.1002/mds.23295
  42. 42.
    Silk TJ, Bellgrove MA, Wrafter P, Mattingley JB, Cunnington R (2010) Spatial working memory and spatial attention rely on common neural processes in the intraparietal sulcus. Neuroimage 53:718–724PubMedCrossRefGoogle Scholar
  43. 43.
    Verny M, Duyckaerts C, Agid Y, Hauw J (1996) The significance of cortical pathology in progressive supranuclear palsy. Clinico-pathological data in 10 cases. Brain 119:1123–1136PubMedCrossRefGoogle Scholar
  44. 44.
    Warrington EK, James M (1991) The visual object and space perception battery. Thames Valley Test Company, Bury St. EdmundsGoogle Scholar
  45. 45.
    Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, Holton JL, Revesz T, Lees AJ (2005) Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP-parkinsonism. Brain 128:1247–1258PubMedCrossRefGoogle Scholar
  46. 46.
    Williams DR, Holton JL, Strand C, Pittman A, de Silva R, Lees AJ, Revesz T (2007) Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson’s syndrome. Brain 130:1566–1576PubMedCrossRefGoogle Scholar
  47. 47.
    Williams DR, Lees AJ (2009) Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 8:270–279PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Emma C. Schofield
    • 1
  • John R. Hodges
    • 1
    • 2
    • 3
  • Thomas H. Bak
    • 5
    • 6
  • John H. Xuereb
    • 4
  • Glenda M. Halliday
    • 1
  1. 1.Neuroscience Research Australia and the University of New South WalesSydneyAustralia
  2. 2.Department of Clinical NeurosciencesUniversity of CambridgeCambridgeUK
  3. 3.MRC Cognition and Brain Sciences UnitCambridgeUK
  4. 4.Department of PathologyUniversity of CambridgeCambridgeUK
  5. 5.Human Cognitive NeuroscienceUniversity of EdinburghEdinburghUK
  6. 6.Centre for Clinical Brain SciencesUniversity of EdinburghEdinburghUK

Personalised recommendations